rs140208785
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_016379.4(VCX3A):c.511G>A(p.Glu171Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016379.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000260 AC: 26AN: 100109Hom.: 0 Cov.: 18 AF XY: 0.00 AC XY: 0AN XY: 26479
GnomAD3 exomes AF: 0.0000443 AC: 8AN: 180511Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66633
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000137 AC: 141AN: 1026504Hom.: 0 Cov.: 40 AF XY: 0.00000294 AC XY: 1AN XY: 340284
GnomAD4 genome AF: 0.000260 AC: 26AN: 100139Hom.: 0 Cov.: 18 AF XY: 0.00 AC XY: 0AN XY: 26525
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.511G>A (p.E171K) alteration is located in exon 3 (coding exon 2) of the VCX3A gene. This alteration results from a G to A substitution at nucleotide position 511, causing the glutamic acid (E) at amino acid position 171 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at